RHUMBLINE ADVISERS - CARDIFF ONCOLOGY INC ownership

CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 93 filers reported holding CARDIFF ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
RHUMBLINE ADVISERS ownership history of CARDIFF ONCOLOGY INC
ValueSharesWeighting
Q1 2022$115,000
-58.9%
46,290
-0.6%
0.00%
Q4 2021$280,000
-11.7%
46,584
-2.2%
0.00%
Q3 2021$317,000
+4.3%
47,650
+4.3%
0.00%
Q2 2021$304,00045,6900.00%
Other shareholders
CARDIFF ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 120,600$299,0000.32%
Artal Group S.A. 750,000$1,860,0000.08%
Eventide Asset Management 1,467,922$3,640,0000.06%
Atom Investors LP 33,798$84,0000.04%
XTX Topco Ltd 25,154$62,0000.03%
ELKHORN PARTNERS LIMITED PARTNERSHIP 19,000$47,0000.02%
Engineers Gate Manager LP 245,567$609,0000.02%
GSA CAPITAL PARTNERS LLP 63,749$158,0000.02%
KENNEDY CAPITAL MANAGEMENT LLC 168,902$419,0000.01%
Walleye Capital LLC 123,305$306,0000.01%
View complete list of CARDIFF ONCOLOGY INC shareholders